Cyrus Biotechnology, Inc., a Seattle-based biotechnology firm with a proprietary software platform for biologics discovery,…
dcorriganDecember 8, 2021
Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate…
dcorriganDecember 7, 2021
A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40…
dcorriganDecember 7, 2021
The Fred Hutch/University of Washington Cancer Consortium has named Dr. Christopher Li its first associate director of…
dcorriganDecember 6, 2021
There’s not a lot known about the new COVID-19 variant Omicron, but what scientists see…
dcorriganDecember 3, 2021
On Dec. 1, Fred Hutchinson Cancer Research Center named computational biologist Dr. Robert Bradley scientific director of…
dcorriganDecember 3, 2021
Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve…
dcorriganDecember 2, 2021
Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of…
dcorriganDecember 2, 2021
Another Greek letter has entered the vernacular. In late November, the World Health Organization designated SARS-CoV-2…
dcorriganDecember 1, 2021
